IAI SPECIAL EDITION: Pharmaceutical care model for antituberculosis drug therapy in tuberculosis patients at a primary healthcare centre in Surabaya, East Java, Indonesia

Authors

  • Yuni Priyandani Universitas Airlangga, Surabaya, Indonesia
  • Abdul Rahem Universitas Airlangga, Surabaya, Indonesia
  • Umi Athiyah Universitas Airlangga, Surabaya, Indonesia
  • M. B. Qomaruddin Universitas Airlangga, Surabaya, Indonesia
  • Kuntoro Universitas Airlangga, Surabaya, Indonesia

DOI:

https://doi.org/10.46542/pe.2022.222.263266

Keywords:

Pharmaceutical care model, Pharmacist, Primary healthcare center, Tuberculosis patient

Abstract

Background: Indonesia ranks third in the world for tuberculosis (TB), which remains a public health problem, where the role of health workers, including pharmacists, is needed. The role of pharmacists in primary health care centres is still limited to providing fixed-dose combination antituberculosis drugs (FDC) as a product. The provision of drugs as a means of therapy through pharmaceutical care in TB patients is still not optimal.   

Objective: This study aimed to create a pharmaceutical care model to improve adherence to FDC treatment regimens in TB patients at the primary health care centre.   

Methods: The study consisted of three stages, with the unit of analysis being pharmacist. The first stage was mapping the profile of FDC services in TB patients. The second stage was the creation of pharmaceutical care training modules. The third stage was testing the pharmaceutical care model with module training for pharmacists. The first stage of the study was an observational analytic cross-sectional design, including 63 pharmacists and 249 TB patients from July to September 2018. The third stage of the study was a quasi-experimental design with a pre-test post-test control group in October 2018, enrolling 36 pharmacists divided into 18 pharmacists in the intervention group and 18 pharmacists in the control group. The research was approved by the Health Research Ethics Commission, Faculty of Public Health, Universitas Airlangga.

Results: The results consisted of a model of pharmaceutical care in TB patients. Pharmacists knowledge affects their abilities, including verification, explanation of indications, effectiveness, safety, and adherence. Pharmacists ability to influence patient response includes belief, understanding, expectation, concern, and adherence to the drug therapy regimen.   

Conclusion: The pharmaceutical care model improved adherence to the FDC therapy regimen in TB patients at the primary healthcare centre.

Author Biographies

Yuni Priyandani, Universitas Airlangga, Surabaya, Indonesia

Faculty of Pharmacy

Abdul Rahem, Universitas Airlangga, Surabaya, Indonesia

Faculty of Pharmacy

Umi Athiyah, Universitas Airlangga, Surabaya, Indonesia

Faculty of Pharmacy

M. B. Qomaruddin, Universitas Airlangga, Surabaya, Indonesia

Faculty of Public Health

Kuntoro, Universitas Airlangga, Surabaya, Indonesia

Faculty of Public Health

References

Athijah, U., (2007), Model Asuhan Kefarmasian Pelayanan Obat yang Diresepkan dan Pengaruhnya terhadap Perilaku Apoteker dalam asuhan Kefarmasian, Disertasi, Program Studi Ilmu Kedokteran Universitas Airlangga, Surabaya

Cipolle R.J., Strand L.M. & Morley P.C., (1998). Pharmaceutical Care Practice, New York: McGraw Hill

Cipolle R.J., Strand L.M. & Morley P.C., (2012). Pharmaceutical Care Practice The Patient-Centered Approach to Medication Management, Third Edition. New York: McGraw-Hill

Hulley, S., Cummings, S., Browner, W., Grady, D., Hearst, N. & Newman, T. (2001). Designing Clinical Research An Epidemiologic Approach. Philadelphia, Lippincott Williams & Wilkins

Hussar D.A., (2005), Patient Compliance, Remington: The Science and Practice of Pharmacy, 21st Edition, p. 1782-1792

Kementerian Kesehatan RI, (2014), Direktorat Jenderal Pengendalian Penyakit dan Penyehatan Lingkungan, Pedoman Nasional Pengendalian Tuberkulosis, Jakarta

Kementerian Kesehatan RI, (2016), Peraturan Menteri Kesehatan Republik Indonesia Nomor 74 Tahun 2016, Standar Pelayanan Kefarmasian di Puskesmas. Jakarta

Komalasari, O. 2013. Pengaruh Konseling Metode Perilaku terhadap Kepatuhan Pengobatan Klien TB Paru Fase Intensif di Wilayah Kerja Dinas Kesehatan Kabupaten Karawang. Tesis, Universitas Padjadjaran

Paes, A.H., Bakker, A., Soe-Agnie, C.J., (1998), Measurement of Patient Compliance, Pharmacy World & Science, 20(2), 73-77. https://doi.org/10.1023/A:1008663215166

Pickard, A. S. & Hung, S. Y. (2006). An Update on Evidence of Clinical Pharmacy Services' Impact on Health-Related Quality of Life. The Annals of Pharmacotherapy, 40(9), 1623-1634. https://doi.org/10.1345/aph.1G653

WHO, (2003), Adherence to Long-Term Therapies, Evidence for Action, World Health Organization, p.123-131

WHO, (2020), Global tuberculosis report 2020, World Health Organization

Yasin, N.M., Wahyono Djoko, Riyanto BS., Sari IP. (2017). Peningkatan Peran Apoteker dan Outcome Pasien Tuberkulosis Melalui Uji Coba Model Training-Education-Monitoring-Adherence-Networking (TEMAN) Apoteker. Jurnal Farmasi Klinik Indonesia, 6(4), 247–266, ISSN: 2252–6218. https://doi.org/10.15416/ijcp.2017.6.4.247

Downloads

Published

2022-03-31

How to Cite

Priyandani, Y. ., Rahem, A. ., Athiyah, U. ., Qomaruddin, M. B. ., & Kuntoro. (2022). IAI SPECIAL EDITION: Pharmaceutical care model for antituberculosis drug therapy in tuberculosis patients at a primary healthcare centre in Surabaya, East Java, Indonesia. Pharmacy Education, 22(2), p. 263–266. https://doi.org/10.46542/pe.2022.222.263266

Issue

Section

Special Edition